Compare NPO & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NPO | CAI |
|---|---|---|
| Founded | 2002 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 6.2B |
| IPO Year | 2002 | 2025 |
| Metric | NPO | CAI |
|---|---|---|
| Price | $307.37 | $29.49 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 14 |
| Target Price | ★ $389.50 | $30.38 |
| AVG Volume (30 Days) | 159.0K | ★ 4.8M |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | ★ 0.41% | N/A |
| EPS Growth | N/A | ★ 69.79 |
| EPS | ★ 2.55 | N/A |
| Revenue | ★ $1,532,000,000.00 | $812,033,000.00 |
| Revenue This Year | $15.07 | $26.75 |
| Revenue Next Year | $7.82 | $19.16 |
| P/E Ratio | $122.04 | ★ N/A |
| Revenue Growth | 16.98 | ★ 96.97 |
| 52 Week Low | $202.00 | $14.19 |
| 52 Week High | $390.42 | $33.65 |
| Indicator | NPO | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 47.63 | 55.16 |
| Support Level | $293.51 | $16.52 |
| Resistance Level | $324.19 | $32.89 |
| Average True Range (ATR) | 10.02 | 1.84 |
| MACD | 0.27 | -0.46 |
| Stochastic Oscillator | 25.24 | 51.35 |
Enpro Inc formerly EnPro Industries Inc is a United States-based company that designs, develops, manufactures, and markets proprietary engineered industrial products. The company operates through two segments: Sealing Technologies, which derives maximum revenue, manufactures and markets sealing products, wheel-end components & systems; and Advanced Surface Technologies, which manufactures wafer processing sub-systems, thin-film coatings, optical filters, and other services like cleaning, coating, testing, and refurbishment. Its geographical segments are the United States, Europe, and other foreign countries.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.